Modern Rheumatology

Papers
(The median citation count of Modern Rheumatology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Comparison between the BioPlex 2200 ANA Screen™ and a conventional method with respect to the detection of autoantibodies91
The serum immunoglobulin G titres against Porphyromonas gingivalis as a predictor of clinical response to 1-year treatment with biological disease-modifying antirheumatic drugs in rheumatoid ar39
Characteristics of patients presenting with concomitant carpal tunnel syndrome at the initial diagnosis with rheumatoid arthritis30
Correction to: Long-term safety and efficacy of belimumab in Japanese patients with SLE: A 7-year open-label continuation study27
The effectiveness and safety of subcutaneous methotrexate injection in Japanese patients with rheumatoid arthritis in a real-world setting27
Changes in treatment adherence and behaviour during the COVID-19 pandemic in Japanese patients with rheumatoid arthritis: Results from cross-sectional study in the IORRA cohort27
Consideration of useful patient-reported outcome measures to identify the unmet medical needs of children and adults with autoimmune and autoinflammatory diseases26
The dietary acid load is associated with disease severity in psoriatic arthritis25
Expert perspectives on pathological findings in vasculitis23
Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: A 48-week interim analysis of the MARS study23
The trends in the prevalence of arthritis and arthralgia and their associations with extra-articular manifestations in patients with Behcet’s disease: A systematic review and meta-analysis22
IL-18 receptor-α signalling pathway contributes to autoantibody-induced arthritis via neutrophil recruitment and mast cell activation21
Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor: A narrative review21
COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease19
Antiphospholipid antibody positivity and the thrombotic risk in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis17
Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments: An interim analysis of a post-marketing surveillance17
1 mg/day or 10 mg/week? Folic acid supplementation with methotrexate in rheumatoid arthritis17
Assessing the efficacy of haemoperfusion for dermatomyositis-associated acute exacerbation of interstitial lung disease: A multicentre retrospective study15
Rheumatoid factor value for determining the first biologic agent to use for non-systemic juvenile idiopathic arthritis15
Correction to: Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs15
Illustrations of rheumatoid arthritis symptoms to promote communication between patients and physicians15
Safety and efficacy of switching immunosuppressive drugs for maintenance treatment in patients with systemic lupus erythematosus: A retrospective cohort study15
Prevalence of social frailty in patients with rheumatoid arthritis: Data from a multicentre observational study (T-FLAG study)14
The bioimpedance phase angle may be associated with frailty in rheumatoid arthritis patients: Results from a prospective, cohort study14
Comparison of safety and effectiveness between etanercept biosimilar LBEC0101 and reference in patients with rheumatoid arthritis in real-world data using the KURAMA cohort14
Development and validation of case-finding algorithms for identifying patients with systemic lupus erythematosus in an administrative claim database from tertiary care centers in Japan14
Similarity and difference between systemic lupus erythematosus and NZB/W F1 mice by multi-omics analysis13
Early full weight-bearing and gait exercise after cemented total ankle arthroplasty with a modified anterolateral approach12
Gut microbiota-immune axis in the regulation of rheumatoid arthritis: from mechanism to precision probiotic strategies12
Age-related differences in the clinical phenotypes of Behçet’s disease: The experience of two referral centres12
Clinical Implications of Vasculitis Associated with Familial Mediterranean Fever: A Comparative Study in Childhood12
Efficacy of anifrolumab in systemic lupus erythematosus patients with serological manifestations: A post hoc analysis of the Japan subgroup of the TULIP-2 trial12
Investigating the subchondral trabecular bone microstructure in patients with osteonecrosis of the femoral head using multi-detector row computed tomography11
Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-onset systemic sclerosis11
VE-cadherin may suppress inflammation depending on the phase of inflammation of rheumatoid arthritis11
Association between the timing of intravenous immunoglobulin treatment and severity of Kawasaki disease11
Can the affected intestinal segment visualized on abdominal ultrasound predict gastrointestinal tract bleeding in immunoglobulin A vasculitis?11
Effectiveness and safety of tocilizumab, an anti–interleukin-6 receptor antibody, in 342 Japanese patients with multicentric Castleman disease: a 3-year, prospective, observational study11
Predictors of damage accrual in patients with antineutrophil cytoplasmic antibody–associated vasculitis: A nationwide prospective study10
The aberrant levels of decorin induce damages of human salivary gland epithelial cells and polarization of macrophages10
Contribution of the factors to EuroQol 5 Dimensions in rheumatoid arthritis patients achieving low disease activity/remission with abatacept treatment: Post hoc subgroup analyses of the Japanes10
Effectiveness and safety of low-energy shock wave therapy for digital ulcers associated with systemic sclerosis: A Phase 3 pivotal clinical trial10
Reasons and risk factors for discontinuation of treatment with any biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: A long-term observational study10
Evaluation of Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody–associated vasculitis compared to ACR/EULAR 2022 classification criteria10
Heating of the neck or elbows alleviates Raynaud’s phenomenon but has different effects on different types of patients with systemic sclerosis10
Risk factors for denosumab discontinuation in patients with postmenopausal osteoporosis9
Impact of ongoing glucocorticoid use on postoperative complications following total knee arthroplasty: a Japanese nationwide propensity score–matched cohort study9
Inflammation markers as risk factors for hypertension in primary Sjögren’s syndrome9
Real-world treatment of gout and asymptomatic hyperuricaemia in Japan9
Questionnaire survey on the prevention and development of cervical cancer in patients with systemic lupus erythematosus in Japan9
Subcutaneous administration of methotrexate in children with paediatric rheumatic diseases9
Analysis of the saliva microbiome in patients with immunoglobulin G4–related disease9
Safety and effectiveness of ixekizumab in Japanese patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis in real-world use: a post-marketing safety study9
Diagnostic values and relevant factors of lumbar posterior lesions in axial spondyloarthritis9
Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naïve patients with rheumatoid arthritis: Post hoc analysis of a 8
Structural, nonclinical, and clinical features of ozoralizumab: A novel tumour necrosis factor inhibitor8
Three-year safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Final analysis of an all-case postmarketing surveillance study8
Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3)8
Significant association of HLA-A26 with uveitis and gastrointestinal involvement in patients with Behçet’s disease in a multicentre study8
Effectiveness of tacrolimus concomitant with biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis8
Successful treatment of systemic lupus erythematosus with residual disease activity by switching from belimumab to anifrolumab8
A unified serum IgG4 cut-off level for the diagnosis of IgG4-related disease using a wide array of kits8
Validation of the MCK model for predicting outcomes in myopathy-associated interstitial lung disease: a multicentre MYKO cohort study8
Prognostic nutritional index as an indicator for the development of bone fragility fracture in patients with rheumatoid arthritis8
The role of ultrasound and FDG-PET/CT to detect extracranial artery involvement in patients with suspected large vessel vasculitis8
High plasma homocysteine level is associated with increased prevalence of the non-remission state in rheumatoid arthritis: Findings from the KURAMA cohort8
Validation of the 2019 EULAR/ACR classification criteria and clinical characteristics of childhood-onset Japanese patients with systemic lupus erythematosus8
Comparison of effectiveness of methotrexate in patients with late-onset versus younger-onset rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J)8
Pearls and pitfalls in imaging of axial spondyloarthritis for rheumatologists7
Drug-survival profiling of second-line biologic therapy in rheumatoid arthritis: Choice of another tumour necrosis factor inhibitor or a biologic of different mode of action?7
A clinical overview of paediatric sarcoidosis: Multicentre experience from Turkey7
Symptoms compatible with Rome IV functional bowel disorder in patients with ankylosing spondylitis7
Efficacy and safety of anakinra for acute calcium pyrophosphate deposition disease flare: a systematic review and meta-analysis7
Kynurenine pathway of tryptophan metabolism in patients with familial Mediterranean fever7
Efficacy and safety of febuxostat in Japanese paediatric patients with hyperuricaemia including gout: Phase 2, single arm, open‒label, multicentre studies7
Non-B27 HLA-B alleles lack diagnostic value, necessitating composite clinical indices to distinguish axial spondyloarthritis from radiographic mimics in Japanese patients7
Prevalence of high and low serum alkaline phosphatase levels and the associated factors in patients with rheumatoid arthritis: Results from the IORRA cohort study7
Severe COVID-19 in patients with immune-mediated rheumatic diseases: A stratified analysis from the SORCOM multicentre registry7
Mortality and risk factors in Japanese patients with rheumatoid arthritis: a 14-year observation of the IORRA cohort7
Assessment of muscle quality and quantity in individuals with diffuse idiopathic skeletal hyperostosis7
Characteristics of patients with polymyalgia rheumatica based on glucocorticoid dose in Japan: A cohort study using routinely collected health data7
The efficacy and safety of anifrolumab in Japanese patients with systemic lupus erythematosus: TULIP-2 subanalysis7
Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: A retrospective, multi-center descriptive study: Comment on the article by Na7
Severity scores, damage indices, and the concept of the colchicine-resistant patient in familial Mediterranean fever7
Elucidation of factors influencing spinal ankylosis in patients with axial spondyloarthritis7
Response to Dr Urata’s Letter to the Editor of Modern Rheumatology regarding a study of “Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders”7
Safety and effectiveness of peficitinib 100 mg/day in patients achieving clinical remission from a long-term open-label extension study in Japan, Korea, and Taiwan (RAJ2)7
Comparisons between US norm-based two-component and Japanese norm-based three-component SF-36 summary scores in systemic lupus erythematosus patients6
The relationship between locomotive syndrome and depression in young Chinese college students6
Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study6
Neck pain and related factors in patients with rheumatoid arthritis6
Gender differences in patient experience in idiopathic inflammatory myopathies: Subanalysis from the COVAD dataset6
Elevated serum heparin-binding protein levels in patients with gout flare6
Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Results from a 24-week post-marketing surveillance study6
Polypharmacy prevalence and associated factors in patients with systemic lupus erythematosus: A single-centre, cross-sectional study6
Predictors of disease course in systemic juvenile idiopathic arthritis6
Factors associated with osteoporosis and fractures in patients with systemic lupus erythematosus: Kyoto Lupus Cohort6
Association of bisphosphonate with bone loss and pain-related behaviour in an adjuvant-induced osteoporosis model6
Comprehensive assessment of patients with symptomatic hand osteoarthritis: Cross-sectional insights into links with other joints6
Impact of deep remission on renal flare in pure class V lupus nephritis: results from KEIO-SLE cohort, a retrospective cohort study6
Gene regulatory network study of rheumatoid arthritis in single-cell chromatin landscapes of peripheral blood mononuclear cells6
Assessment of the dorsal tangent of the metacarpal neck as an intraoperative reference for metacarpophalangeal joint arthroplasty6
A multicentre study of clinical features and HLA typing in Japanese patients with ankylosing spondylitis6
Radiographic study of the distal ulna in rheumatoid arthritis with extensor digitorum communis ruptures6
Telemedicine for paediatric rheumatic diseases in Japan: a national survey of physicians’ perspectives6
Laboratory markers predicting tofacitinib efficacy in Japanese patients with rheumatoid arthritis: A pooled analysis of Phase 2/3 randomised controlled clinical trials6
Feasibility and applicability of locomotive syndrome risk test in elderly patients who underwent total knee arthroplasty6
Verification of unmet medical needs in patients with juvenile idiopathic arthritis in Japan6
Non-infectious uveitis referred for pediatric rheumatologic assessment and management: A Portuguese retrospective study6
Management review of scleroderma renal crisis: An update with practical pointers6
Prognostic factors affecting respiratory-related death in patients with rheumatoid arthritis complicated by interstitial lung disease: An ANSWER cohort study6
Evaluation of articular cartilage degeneration in patients with osteonecrosis of the femoral head using T2 mapping magnetic resonance imaging6
Differences in sex- and age-associated mortality in patients with anti-MDA5-positive dermatomyositis6
Prevalence, patient characteristics and treatment patterns among systemic lupus erythematosus–pulmonary arterial hypertension patients in real-world clinical practice: A retrospective analysis of Medi6
Relationship between the phase angle from bioelectrical impedance analysis and daily physical activity in patients with rheumatoid arthritis5
Cut-off values for achieving osteoporosis treatment goals in women with rheumatoid arthritis receiving denosumab5
Factors associated with frailty in rheumatoid arthritis patients with decreased renal function5
Intervertebral fusion sites in patients with ankylosing spondylitis: A computed tomography study5
Romosozumab increases bone mineral density in Japanese older adults with osteoporosis5
Mid- to long-term outcomes of high tibial osteotomy in patients with rheumatoid arthritis5
Arm heating to relieve Raynaud’s phenomenon in systemic sclerosis: A single-arm multicentre prospective clinical trial5
New aspects of clinical and immunological characteristics in patients with anti-asparaginyl tRNA synthetase (anti-KS) autoantibody5
Challenges nurses face in providing care to older patients with rheumatoid arthritis: A qualitative study5
A multicentre, large-scale, observational study of tocilizumab in patients with giant cell arteritis in Japan5
Frozen shoulder. An overview of pathology and biology with hopes to novel drug therapies5
Risk factors for cytomegalovirus reactivation during the treatment of ANCA-associated vasculitis: A retrospective cohort study of the J-CANVAS study5
PREDICT-crFMF score: A novel model for predicting colchicine resistance in children with familial Mediterranean fever5
Iguratimod versus salazosulfapyridine in rheumatoid arthritis patients with an inadequate response to methotrexate: Adjusted with propensity score matching5
Prospective follow-up of patients with probable Behçet’s disease: first results of an inception cohort5
Development and validation of a clinical model for predicting the severity of carpal tunnel syndrome5
Nation wide cohort study of Japanese patients with ANCA associated vasculitis using rituximab Effectiveness and safety after two years5
Challenges nurses face in providing care for patients with juvenile idiopathic arthritis5
Grip Strength Asymmetry as a Better Indicator of Residual Hand Symptoms than Absolute Grip Strength After Achieving Treat-To-Target in Rheumatoid Arthritis5
Risk factor analysis of vertebral fractures requiring surgery in patients with ankylosing spondylitis5
Association of spinal ankylosis with spinal mobility and functional impairment in radiographic axial spondyloarthritis: A computed tomography study5
A multicentre, prospective registry of patients with systemic sclerosis in Japan: baseline patient characteristics5
Impact of pain in other body regions on the foot-specific quality of life in patients with hallux valgus5
Large language model may assist diagnosis of SAPHO syndrome by bone scintigraphy5
Trends and Health Inequalities in the global, regional, and national prevalence of Rheumatoid Arthritis from 1990 to 2021: Insights from the Global Burden of Disease Study 20215
Correction to: Anti-arthritic effects of polyunsaturated fatty acid–rich supplementation combined with selective soluble epoxide hydrolase inhibitors in a collagen-induced arthritis mouse model5
Coffee consumption may suppress development of metabolic syndrome in patients with rheumatoid arthritis—TOMORROW study4
Leucine-rich α2-glycoprotein as a useful biomarker for evaluating disease activity in rheumatoid arthritis4
Serum creatinine is more strongly associated with hyperuricemia than eGFR in males but not in females4
On the determinants of IDO activity in patients with familial Mediterranean fever4
Influences of advanced age in rheumatoid arthritis: A multicentre ultrasonography cohort study4
Interferons dominate damage and activity in juvenile scleroderma4
Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results4
The need for telemedicine for rheumatic diseases in adult medical care: a survey of nonpaediatric rheumatologists4
Serosal involvement in adult-onset Still’s disease: A multicentre and retrospective study4
Association of disease activity using SDAI and DAS28, but not JADAS-27, with subsequent changes in physical function in adult patients with juvenile idiopathic arthritis4
Retention of baricitinib-treated patients with rheumatoid arthritis in Japan: Interim results from a prospective observational cohort study4
Vitamin D status-associated postoperative complications in patients with hip dysplasia after periacetabular osteotomy: A case–control study4
Effects of cyclophosphamide administration on ovarian dysfunction in pediatric patients with connective tissue diseases: A systematic scoping review4
The relationship of centralized pain in fibromyalgia syndrome with sleep, fatigue and quality of life4
Development of a nursing practice scale for rheumatoid arthritis treatment with biological disease-modifying anti-rheumatic drugs4
Rituximab versus intravenous cyclophosphamide for anti-neutrophil cytoplasmic antibody-associated vasculitis with severe renal impairment: A multicentre 4
Development of quality indicators for pregnancy and childbirth in patients with systemic lupus erythematosus4
Clinical profile and outcome of large-vessel giant cell arteritis in Japanese patients: A single-centre retrospective cohort study4
Usefulness of ultrasound as a predictor of elderly-onset rheumatoid arthritis with polymyalgia rheumatica-like onset4
Cardiac magnetic resonance imaging analysis of cardiac involvement in eosinophilic granulomatosis with polyangiitis4
Association of denosumab with serum cytokines, chemokines, and bone-related factors in patients with rheumatoid arthritis: A post hoc analysis of a multicentre, open-label, randomised, parallel4
Real-world use of biologics for systemic juvenile idiopathic arthritis: Information from a Japanese hospital claims database4
Correction to: Nation-wide cohort study of remission induction therapy using rituximab in Japanese patients with antineutrophil cytoplasmic antibody–associated vasculitis: Effectiveness and safety in 4
Factors associated with impaired physical function in elderly rheumatoid arthritis patients who had achieved low disease activity4
Rituximab in the real-world treatment of lupus nephritis: A retrospective cohort study in Japan4
Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography and computed tomography for differentiating polymyalgia rheumatica and rheumatoid arthritis: Using classification and regression4
Correction to: Development of a nursing practice scale for rheumatoid arthritis treatment with biological disease-modifying anti-rheumatic drugs4
Real-world clinical decisions of physicians in the management of Takayasu arteritis and giant cell arteritis in Japan: A cross-sectional web questionnaire survey4
Pregnancy and childbirth in Takayasu arteritis in Japan: A nationwide retrospective study4
A retrospective, longitudinal study of rheumatoid arthritis treatment patterns with Janus kinase inhibitors and other disease-modifying antirheumatic drugs in Japan4
Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs: Evaluation of4
Modified pustulotic arthro-osteitis diagnostic guidance 2022 – Modified Sonozaki criteria – Secondary publication4
Investigation of treatment continuity, usefulness, and nocebo effect in switching from the original etanercept to its biosimilar in patients with rheumatoid arthritis: A JET observational study in Jap4
Relationship between falls and the use of hypnotics, antidepressants, antipsychotics, and anxiolytics in patients with rheumatoid arthritis: A cross-sectional study4
Assessment of clinical and radiological characteristics of Japanese patients with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome4
Safety and effectiveness of canakinumab in Japanese patients with cryopyrin-associated periodic syndrome: final results from a post-marketing surveillance in Japan4
Immunological biomarkers in patients with radiographic axial spondyloarthritis, an exploratory longitudinal Swedish study3
Comparative renoprotective effectiveness of allopurinol and febuxostat among hyperuricaemic patients with preserved kidney function3
Benefits and risks of haematopoietic stem cell transplantation for systemic sclerosis: A systematic review and meta-analysis3
Perspectives on current and emerging therapies for immunoglobulin G4–related disease3
Post hoc analysis of patients with rheumatoid arthritis under clinical remission in two Japanese Phase 3 trials of peficitinib treatment (RAJ3 and RAJ4)3
Magnetic resonance imaging screening for osteonecrosis of the femoral head after coronavirus disease 20193
Mid-term outcomes of distal tibial oblique osteotomy for rheumatoid arthritis–associated ankle arthropathy: A comparison with osteoarthritis outcomes3
Factors related to acceptance of COVID-19 vaccine booster doses among patients with autoimmune and rheumatic diseases in Japan: A single-centre cross-sectional survey3
Increased risk of malignancy in HLA-B27-positive patients with ankylosing spondylitis requiring biologics for sustained inflammation: A long-term, single-center retrospective study3
The impact of social frailty and physical function on laughter frequency in rheumatoid arthritis patients: data from a multicenter observational study (Tsurumai-frailty and locomotive syndrome of rheu3
Chemoprophylaxis against Pneumocystis jirovecii pneumonia in Japanese patients with ANCA-associated vasculitis: An observational study3
Spontaneous remission of giant cell arteritis3
Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past 17 years: Analyses from the IORRA cohort3
Long-term evaluation of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs3
Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 years3
Clinical investigation for the mechanisms of anaphylactic symptoms in osteoarthritis patients after diclofenac etalhyaluronate administration3
Recent progress on the treatment of type 1 autoimmune pancreatitis and IgG4-related disease3
Factors associated with treatment discontinuation and age-stratified safety of abatacept in Japanese patients with rheumatoid arthritis: 5-year results of the ORIGAMI study3
Number needed to treat and cost per responder of Janus kinase inhibitors approved for the treatment of moderate-to-severe rheumatoid arthritis in Japan3
Blood monocyte fraction and computed tomography attenuation value of bone marrow in fever of unknown origin: A retrospective analysis for differentiating adult-onset Still’s disease and intravascular 3
The importance of small joint involvement in oligoarticular juvenile idiopathic arthritis3
Does the alcohol flushing response modify the relationship between alcohol consumption and the risk of developing osteonecrosis of the femoral head? A multicenter case–control study in Japan3
Autoantibodies in lupus nephritis useful in distinguishing proliferative nephritis from membranous nephritis3
Hyperglobulinemia predicts increased risk of mortality in primary Sjögren’s syndrome: Based on a Chinese multicentre registry3
Efficacy of golimumab in rheumatoid arthritis patients at high risk of a poor prognosis: Post hoc analysis of GO-FORTH study using cluster analysis3
Assessing the diagnostic and therapeutic value of submandibular gland elastography in patients with immunoglobulin G4-related sialadenitis3
Clinical efficacy of alternative TNF inhibitor and secukinumab between primary non-responder and secondary non-responder of prior TNF inhibitor in ankylosing spondylitis3
Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: Analyses from a 14-year observation of the IORRA cohort3
Prevalence of systemic lupus erythematosus and age-stratified treatment trends in the Japanese population: A cross-sectional study based on the National Database of Health Insurance Claims3
Knee joint dysfunction in the patients immediately before arthroplasty was well reflected by locomotive syndrome, not physical frailty3
Prevalence and risk factors of monoclonal gammopathy in patients with autoimmune inflammatory rheumatic disease: A systematic review and meta-analysis3
Clinical features of polymyalgia rheumatica patients in Japan: Analysis of real-world data from 2015 to 20203
Association of anti-citrullinated protein antibodies with changes in bone density in patients with rheumatoid arthritis treated with romosozumab for one year: A cohort study3
Correction to: Expert perspectives on pathological findings in vasculitis3
Correction to: Impact of denosumab discontinuation on changes in bone mineral density and bone erosion in rheumatoid arthritis patients3
Decreased foot-related quality of life is a risk factor for falls in patients with rheumatoid arthritis3
Comparative analysis of low-field magnetic resonance imaging in patients with rheumatoid arthritis treated with certolizumab pegol or infliximab3
Incidence of opportunistic infections in patients with rheumatoid arthritis treated with different molecular-targeted drugs: A population-based retrospective cohort study3
Association between patient-reported outcomes and impairments in work and activity in patients with rheumatoid arthritis in clinical remission: A retrospective analysis using the IORRA database3
COVID-19 vaccination in patients with rheumatic diseases leads to a high seroconversion rate and reduced self-imposed isolation and shielding behaviour3
Evaluation of medication withdrawal in patients with non-systemic juvenile idiopathic arthritis in Japan using a web-based survey3
Impact of Janus kinase inhibitors on antibody response to 13-valent pneumococcal conjugate vaccine in patients with rheumatoid arthritis3
Safety and effectiveness of baricitinib for rheumatoid arthritis in Japanese clinical practice: 24-week results of all-case post-marketing surveillance3
Role of musculoskeletal ultrasound in diagnosing and managing chronic inflammatory arthritis in overweight and obese patients: a narrative review3
Comparison of the clinical outcomes following total knee arthroplasty in osseous ankylosed and non-ankylosed knees using propensity-score matching2
Predicting outcomes after total knee arthroplasty using intraoperative knee kinematics measured by navigation2
Natural history of Behçet’s disease focusing on remission of oral ulcers2
Add-on effectiveness of methotrexate or iguratimod in patients with rheumatoid arthritis exhibiting an inadequate response to Janus kinase inhibitors: The ANSWER cohort study2
Addressing the disease burden of systemic lupus erythematosus2
Mortality and associated factors in patients with systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease: A long-term follow-up study2
Efficacy of belimumab in patients with systemic lupus erythematosus from North East Asia: Results of exploratory subgroup analyses2
Intravenous immunoglobulin treatment for obstetric antiphospholipid syndrome refractory to conventional therapy: A single-arm, open-labelled multicentre clinical trial2
Clinical characteristics of rheumatoid arthritis patients complicated with pulmonary nontuberculous mycobacterial disease: A cross-sectional case series study2
Joint involvement patterns and patient-reported satisfaction in difficult-to-treat rheumatoid arthritis: results from the multicentre observational cohort, FRANK Registry2
Time to normalisation of C-reactive protein and incidence of relapse in microscopic polyangiitis: A medical records review study in Japan2
Telemedicine as an alternative to in-person care in the field of rheumatic diseases: A systematic scoping review2
Comparative clinical practice of juvenile idiopathic arthritis and rheumatoid arthritis in adolescents and young adults: A retrospective cohort study using Japanese health insurance claims data (2016–2
Modified-Mesenchymal Stem Cells as an Innovative Therapeutic Approach in Systemic Lupus Erythematosus (SLE); A Comprehensive Review2
Upper extremity function and strength, assessed with unsupported upper limb exercise test, is impaired in patients with Takayasu arteritis2
Locomotive syndrome and depressive symptoms: A cross-sectional study in middle-aged women2
Outcomes and risk factors for mortality in Pneumocystis pneumonia patients with rheumatoid arthritis: A multicentre retrospective cohort study2
Protracted febrile myalgia as a first and challenging manifestation of familial Mediterranean fever2
Influence of Janus kinase inhibitors on early postoperative complications in patients with rheumatoid arthritis undergoing orthopaedic surgeries2
Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration2
Efficacy and safety of tumor necrosis factor inhibitors for systemic juvenile idiopathic arthritis: A systematic review2
Screening for familial disease presence in first-degree relatives of Behçet’s disease patients: Is measurement of common femoral vein wall thickness valuable for the diagnosis?2
Effects of regional variations and occupation on hand osteoarthritis: Insights from the research on osteoarthritis/osteoporosis against disability study2
Comparison of clinical and radiographic results of mobile-bearing total ankle arthroplasty between osteoarthritis and rheumatoid arthritis2
Correction to: Rituximab in the real-world treatment of lupus nephritis: A retrospective cohort study in Japan2
Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance2
Interferon-alpha 1 expression indicates the disease activity and response of patients with ankylosing spondylitis to anti-TNF-α treatment2
Antinuclear antibodies staining patterns and titres in juvenile idiopathic arthritis2
Relationships between inflammation markers and the risk of hypertension in primary Sjögren’s syndrome: A retrospective cohort study2
Clinical and immunological effects of hydroxychloroquine in patients with active rheumatoid arthritis despite antirheumatic treatment2
0.073856115341187